Agios Pharmaceuticals Inc. buy Citigroup Inc.
Start price
29.11.25
/
50%
€25.20
Target price
29.11.26
-
Performance (%)
-16.67%
Price
23.12.25
€21.00
Summary
This prediction is currently active. The prediction for Agios Pharmaceuticals Inc. disappoints with a performance of -16.67%. This prediction currently runs until 29.11.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Agios Pharmaceuticals Inc. | 0.000% |
| iShares Core DAX® | 0.224% |
| iShares Nasdaq 100 | 0.371% |
| iShares Nikkei 225® | 0.972% |
| iShares S&P 500 | 0.417% |
Comments by Citigroup_Inc_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat